School of Sport Exercise and Rehabilitation Sciences, University of Birmingham
Birmingham, B15 2TT, United Kingdom
NCT Number: NCT02624011
This study will investigate the influence of increased sedentary time on long-term measures of muscle protein synthesis and metabolic health. The investigators will test the hypothesis that increased time spent in sedentary behaviours will lead to a reduction in long-term measures of muscle protein synthesis and compromised metabolic health.
Looking for future studies?
Notify Me18 year–35 year
Male
Interventional
Not applicable
Birmingham, B15 2TT, United Kingdom
Sarcopenia, the loss of muscle mass with age, is thought to be accelerated by an inactive, sedentary lifestyle. Increased sedentary time has consistently been associated with lower muscle mass and compromised metabolic health. However, there is currently a lack of direct evidence to support these associations.
Therefore, this study will investigate whether increased sedentary time (reduced step count and exercise cessation) directly influences long-term measures of muscle protein synthesis and metabolic health in young, active adults. Following a 7 day period of normal habitual physical activity, participants will undertake a 7 day period of step reduction and exercise cessation. It is hypothesised that 7 days of increased sedentary time will result in a reduction in long-term rates of muscle protein synthesis and a worsening of metabolic health.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Young, active participants will undergo a 7 day period of habitual physical activity followed by a 7 day period of step reduction and exercise cessation.
Time frame: 0-14 days
Long-term muscle protein synthesis (FSR %/day) will be determined using deuterium oxide (D2O) to compare muscle protein synthesis rates over the first 7 day period and the second 7 day period.
Time frame: For 20 minutes at day 7 and day 14
Whole body oxygen consumption (VO2, L/min) and carbon dioxide production (VCO2, L/min) at rest will be measured using indirect calorimetry to calculate the rate of fat oxidation at rest (g/min).
Time frame: At 0, 30, 60, 90 and 120min of the oral glucose tolerance test at day 7 and day 14
Whole body oxygen consumption (VO2, L/min) and carbon dioxide production (VCO2, L/min) following an oral glucose drink will be measured using indirect calorimetry to calculate the rate of fat oxidation during an oral glucose tolerance test (g/min).
Time frame: For 20 minutes at day 7 and day 14
Whole body oxygen consumption (VO2, L/min) and carbon dioxide production (VCO2, L/min) at rest will be measured using indirect calorimetry to calculate the rate of carbohydrate oxidation at rest (g/min).
Time frame: At 0, 30, 60, 90 and 120min of the oral glucose tolerance test at day 7 and day 14
Whole body oxygen consumption (VO2, L/min) and carbon dioxide production (VCO2, L/min) following an oral glucose drink will be measured using indirect calorimetry to calculate the rate of carbohydrate oxidation during an oral glucose tolerance test (g/min).
Time frame: At 0, 30, 60, 90 and 120min of the oral glucose tolerance test at day 7 and day 14
Blood glucose concentration will be assessed in blood samples taken during the oral glucose tolerance test.
Time frame: At 0, 30, 60, 90 and 120min of the oral glucose tolerance test at day 7 and day 14
Blood insulin concentration will be assessed in blood samples taken during the oral glucose tolerance test.
Time frame: At 0, 30, 60, 90 and 120min of the oral glucose tolerance test at day 7 and day 14
Blood fatty acid concentration will be assessed in blood samples taken during the oral glucose tolerance test.
University of Birmingham
Other
Influence of Increased Sedentary Time on Long-term Rates of Skeletal Muscle Protein Synthesis in Young Adults
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07596836
Behavior, Cardiorespiratory Fitness
Ankara, Turkey (Türkiye)
View Trial DetailsNCT03898206
Behavior, Cardiovascular Diseases
Bedford, Bedfordshire, United Kingdom
View Trial DetailsNCT04019119
Back Pain, Behavior
Málaga, Spain
View Trial DetailsNCT04645875
Behavior, Cardiovascular Diseases
Bedford, United Kingdom
View Trial Details